Search Weight Loss Topics:

Page 73«..1020..72737475..8090..»

Home » Testosterone » Page 73

A research report added to the repository of eonmarketresearch.com details the historical data of the global Testosterone Replacement Therapy market and assesses the present market scenario based on the important factors influencing the trajectory of this Testosterone Replacement Therapy market. With the help of primary and secondary data, the Testosterone Replacement Therapy market research report predicts the future of this Testosterone Replacement Therapy market and makes valid projections. Furthermore, the Testosterone Replacement Therapy industry research report also includes insightful inputs from industry experts to help the readers make well-informed business decisions. The Testosterone Replacement Therapy market report also uses SWOT analysis and Porters five forces analysis to highlight the key elements of the Testosterone Replacement Therapy Market.

Global Testosterone Replacement Therapy Market gives insights into the major driving factors, restraints, and major trends in the Testosterone Replacement Therapy market and analyzes their impact on the Testosterone Replacement Therapy markets developmental prospects over the reports forecast period.

The global Testosterone Replacement Therapy market research report takes a chapter-wise approach in explaining the dynamics and trends in the Testosterone Replacement Therapy industry. Divided into 13 chapters, each chapter explains various aspects of the market in absolute detail. The Testosterone Replacement Therapy market report opens with an overview of the Testosterone Replacement Therapy industry, which contains definitions and specifications pertaining to the industry. In the following chapter, the Testosterone Replacement Therapy market report explains the manufacturing cost structure, which includes a thorough analysis of the raw material suppliers and price analysis, equipment suppliers and price analysis, and analysis of labor costs and other costs.

Grab a sample of this report and get instant 10% discount @ https://www.eonmarketresearch.com/sample/58743

The report analyzes the key players in the global Testosterone Replacement Therapy market such as

AbbVieAllerganBayerEli Lilly and CompanyKyowa Kirin InternationalNovartisPfizer

Market Segment by Product Type

General Type

Market Segment by Application

Medical

Market size split by Region North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Malaysia, Philippines, Thailand, Vietnam, Europe, Germany, France, UK, Italy, Russia, Central & South America, Brazil, Rest of Central & South America, Middle East & Africa, GCC Countries, Egypt, South Africa.

Place An Inquiry Before Buying @ https://www.eonmarketresearch.com/enquiry/58743

It also explains the competitive landscape of the Testosterone Replacement Therapy market and the regulatory framework influencing the Testosterone Replacement Therapy market. Furthermore, the Testosterone Replacement Therapy industry report shares details pertaining to the financial overview, research and development activities, investment outlook, business and marketing strategies, and product portfolio of the key players in the global Testosterone Replacement Therapy industry.

The Testosterone Replacement Therapy market report also evaluates the technical data and manufacturing plants analysis, capacity, production, and revenue analysis by type, region, and manufacturers, price, cost, gross, and gross margin analysis, consumption volume, consumption value, and sale price analysis of the Testosterone Replacement Therapy market. The Testosterone Replacement Therapy industry report also offers regional segmentation of the global Testosterone Replacement Therapy market to help the readers understand the specific market drivers, restraints, threats, and opportunities impacting this Testosterone Replacement Therapy market.

About Us:

Eon Market Research (EMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers.

Contact Us:

Eon Market ResearchPhone: +1 703 879 7090Email: sales@eonmarketresearch.com

More:
Global Testosterone Replacement Therapy Market 2025 Forecasts and Analysis with Top Key Players like -AbbVie, Allergan - Fashion Trends News

Higher levels of genetically derived testosterone are associated with an increased risk of type 2 diabetes and polycystic ovary syndrome (PCOS) in women but play a protective role against type 2 diabetes in men, according to a study in Nature Medicine.

Researchers from the United States, United Kingdom, and Europe examined testosterone levels and genetic data from 425,097 patients in the UK Biobank. The researchers investigated 2571 genome-wide significant trait/signal pairs, which ranged from 22 signals for estradiol in men to 658 signals for sex hormone-binding globulin in a sex-combined cohort. The findings from the analyses were verified in the EPIC-Norfolk and Twins UK studies, which demonstrated a high level of agreement with the UK Biobank analysis. Mendelian randomization was also used to identify potential causal associations between testosterone levels and disease risk.

The investigators found differences in genetic determinants of testosterone levels between men and women, with higher testosterone showing harmful and protective effects on women and men, respectively. In women, a genetically determined, per 1-standard deviation (SD) higher level of bioavailable testosterone was associated with an increased risk of type 2 diabetes (odds ratio [OR], 1.37; 95% CI, 1.22-1.53) and PCOS (OR, 1.51; 95% CI, 1.33-1.72). Conversely, a 1-SD higher testosterone level was associated with reduced risk of type 2 diabetes risk in men (OR, 0.86; 95% CI, 0.76-0.98). Testosterone was also associated with an increased risk of estrogen receptor (ER)-positive breast cancer and endometrial cancer.

A limitation of the study was the use of a single large study enriched for healthy, older people to determine genetic variants. According to the investigators, this may have underestimated the effect size of the associated variants.

The investigators concluded that while these findings relating to adverse metabolic effects of testosterone in women may inform clinical practice, it is premature to infer wider beneficial metabolic effects in men.

Disclosure: Several study authors declared affiliations with the pharmaceutical industry. Please see the original reference for a full list of authors disclosures.

Reference

Ruth KS, Day FR, Tyrrell J, et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nat Med. 2020;26(2):252-258.

Link:
High Levels of Genetically Determined Testosterone Lead to Adverse Metabolic Effects in Women - Medical Bag

The testosterone-related genetic variantHSD3B1was found to be associated with earlier castration resistance and shorter overall survival (OS) in men with low-volume metastatic prostate cancer, according to a study published inJAMA Oncology.

Given these findings,HSD3B1may help identify more men who are likely to benefit from escalated androgen receptor axis inhibition beyond gonadal testosterone suppression according to the researchers.1

These findings lay the groundwork for more personalized and effective treatments for prostate cancer, senior author Nima Sharifi, MD, of Cleveland Clinics Lerner Research Institute, said in a press release.2If men carry this specific testosterone-related genetic abnormality we may be able to individualize their therapy.

Using the phase III E3805 Chemo-hormonal Therapy vs Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer (CHAARTED), researchers analyzed 527 available DNA samples and retrospectively determined theHSD3B1germline genotype in 475 white men. The patients were then randomized to castration plus docetaxel (Taxotere) at 75 mg/m2every 3 weeks for 6 cycles or castration alone, and clinical outcomes were evaluated by genotype.

Of the study cohort, 270 patients (56.8%) inherited the adrenal-permissive genotype (1HSD3B1[1245C] allele). Freedom from castration-resistant prostate cancer at 2 years was diminished in men with low-volume disease with the adrenal-permissive (51.0% [95% Ci, 40.9%-61.2%]) compared to the adrenal restrictive genotype (70.5% [95% CI, 60%-80.9%]) (P= 0.01).

At 5 years, OS was worse in men with low volume disease with the adrenal-permissive genotype (57.5% [95% CI, 47.4%-67.7%] vs 70.8% [95% CI, 60.3%-81.3%] [P= 0.03]). Moreover, hazard ratios were 1.89 (95% CI, 1.13-3.14;P= 0.02) for castration-resistant prostate cancer and 1.74 (95% CI, 1.01-3.00;P= 0.045) for death.

There was no association found between genotype and outcomes in men with high-volume disease. Further, there was no interaction between genotype and benefit from docetaxel.

These findings represent a 7-year research story that started at the lab bench and has now reached the patient bedside, said Sharifi. As the team has shown here, incorporating genetic testing in prostate cancer as part of routine care has significant potential to improve treatment success and quality and length of life for men with prostate cancer who carry theHSD3B1(1235C) variant. This work is another step in that direction.

Researchers indicated that further studies are warranted to evaluate whether potent androgen receptor antagonists might directly overcome the tumor growth advantage transmitted by theHSD3B1(1245C) allele and yield particular benefit for patients with low-volume disease who have the adrenal permissive genotype. Moreover, a notable limitation of the study is that the analysis was restricted to white men given that white patients accounted for 85% of all of the trial participants.

This information could assist clinicians in counseling patients and guide researchers in identifying those for whom escalated androgen receptor axis inhibition beyond mere gonadal testosterone suppression is most warranted, the authors wrote. Accordingly,HSD3B1genotype could be used as a stratification factor for patients with low-volume disease in future clinical trials.

References:

1. Hearn JWD, Sweeney CJ, Almassi N, et al.HSD3B1Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer.JAMA Oncology; 2020. doi:10.1001/jamaoncol.2019.6496.

2. Researchers Validate Link Between Genetic Variant and Poor Outcomes in Men with Advanced Prostate Cancer [news release]. Cleveland, Ohio. Published February 13, 2020. newswise.com/articles/researchers-validate-link-between-genetic-variant-and-poor-outcomes-in-men-with-advanced-prostate-cancer?sc=mwhr&xy=10021790. Accessed March 4, 2020.

Go here to read the rest:
HSD3B1 May Be Associated with Earlier Castration Resistance, Shorter OS in Prostate Cancer - Cancer Network

The tide is turning against gender reassigning procedures for minors. I Wikimedia Commons

Judges and legislators across the country are taking up pediatric gender treatment. Finally, our government is prioritizing the protection of children, one of its most important duties, above a parents right to wokeness.

In October, Sydney Wright, an ex-trans man, wrote her story for the Daily Signal called I Spent a Year as a Trans Man. Doctors Failed Me at Every Turn. Embarrassed by the looks shed receive in public while holding hands with girlfriends in high school, Wright became envious of the happy transgender men on Instagram who could.

Without her parents consent, Wright found a therapist who helped her acquire the letter needed to begin a testosterone regimen. When she handed the letter to her doctor, he didnt even open it before writing her prescription. When she asked with surprise if he wasnt going to give her the shot himself, he told her to figure it out at home and to consult YouTube if she needed help.

Six months and 50 pounds later, with pre-diabetes and heart problems, Wright felt trapped. She hadnt found the happiness she sought and was too embarrassed to change her mind about such a grave decision. Wrights grandpa was the first person to ask her to stop the treatments. She quit cold turkey and is finally regaining a sense of normalcy after months in and out of the hospital from withdrawal symptoms.

Wrights story unfortunately isnt special. She tells the story of all those sacrificed on the altar of American wokeness.

Thankfully, judges and legislators are taking notice of stories like Wrights, and the tide is turning. Brave adults are finally daring to admit that they see and hear the voices of the children whose lives are on the line.

Last month, Ohio representatives Ron Hood and Bill Dean introduced the Vulnerable Child Protection Act. If passed into law, the bill would criminalize any medical professional who performs treatment on a minor which changes a childs reproductive anatomy, delays or prevents puberty, or disrupts production of sex hormones such as estrogen and testosterone, among other more widely-accepted violations of medical ethics, like restraining or inflicting pain on a minor.

Rob Hoogland is an Alabama father of a 12-year-old. Last year, his daughters school counselor told her that she was a boy, and the school picked out a boys name and treated her as a boy without informing her parents. Two years later, Hoogland was fighting his 14-year-old in court over the initiation of testosterone treatments. The courts ruled, all too typically, against the will of the parents. Hoogland speaks out now and warns other parents against complacency: Dont think it cant happen to you.

After hearing stories like the Hooglands, the house and senate of Alabama are working to pass a bill similar to Ohios, called the Vulnerable Child Compassion and Protection Act.

It is time for parents, not just lawmakers and judges, to rise to the occasion to fight for the family.

Society has crumbled under the weight of its inverted priorities. A healthy society is structured like a pyramid: first, personhood; then, the family; then, the neighborhood, the community, the state, and finally, the country. This arrangement is called subsidiarity, taken from the Latin subsidias, meaning help. It makes sense, too: the entire structure is ordered toward the priority of the person. The larger orders, like the government, only interfere with the smaller orders, like your local community, when the smaller orders cannot solve the problem on their own.

The entire structure is aimed not at financial equity or distributing privilege, but far more importantly at the dignity of each person. Subsidiarity looks like individuals helping themselves first, and parents protecting their dependent children, and communities helping when parents cant. In the rare circumstances that exceed the abilities of a community, the state will step in. And finally, when all else has failed, the federal government will help.

In our current state of affairs, the individual often turns immediately to federal welfare. The perverse concept of seeking help first from a stranger rather than those closest to us is bolstered by the effects of social media; a major influence in Wrights gender transition were the Instagram snapshots of apparently happy transgender men. Meanwhile, her parents stood by and despaired as they watched their daughter destroy herself. It is easy to see how personal dignity is being smothered, not empowered, by this unstable upside-down pyramid.

The stances taken in Ohio and Alabama are a promising start, but laws wont change the heart of our nation. If we want to protect the youth of America, its up to local communities: Parents ought to stand up for their children, and friends ought to stand up for their friends.

Gender treatment therapy is bad for kids, and its about time we admit it.

Reagan Cool is a senior studying philosophy and religion. She is a columnist on faith and culture.

More:
State courts stand up to woke America and gender therapy - Hillsdale Collegian

Is your idea of getting hot and steamy taking a shower afterspin class? Join the club. Many women discover their libido is lacking,especially as they get older.

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services.Policy

Thats not necessarily a problem, as long as yourecomfortable with the (in)frequency of your romantic dalliances. But it can befrustrating if you miss the intimacy that goes along with sex. And if you andyour partner have mismatched libidos, that can be a big source of relationshipstrife.

Luckily, treatments are available to rev up a sluggish sex drive, says womens health specialist Holly Thacker, MD.

There are all sorts of reasons your sex drive might have shifted into neutral. Pregnancy, breastfeeding and menopause can do a number on your hormones. Stress, illness, medications and relationship challenges can also interfere with sexual desire.

If you notice a dramatic dip in your arousal level, firstrule out any medical causes. Yes, it might feel weird talking to your doctorabout getting frisky, but medical professionals have heard it all. Your Ob/Gynor primary care doctor or womens health specialist can pinpoint problems suchas medication side effects or hormonal changes (like perimenopause) that mightbe interfering with intimacy.

Yet many women experience reduced sexual desire for no obvious reason a condition sometimes called hypoactive sexual desire disorder (HSDD). And in the last few years there has been more research and medical options for this condition. We now have some excellent options, Dr. Thacker says.

Several treatments are available to turn up a womans arousal:

This prescription pill has been available to treat HSDD since 2015. Flibanserin is taken nightly and can ramp up sex drive, says Dr. Thacker. It may cause drowsiness and shouldnt be taken within 2 hours of drinking alcohol.

The downside is it takes about 2 months for the medicationto start working. But for many women (and their satisfied partners), thetreatment is worth the wait.

This on-demand prescription medication was approved totreat HSDD in 2019. Women inject it under the skin at least 45 minutes beforethey anticipate getting frisky.

Dr. Thacker notes that as many as 40% of women experiencenausea after taking the drug. So she suggests this workaround: Take it rightbefore bed and cancel your morning meetings. Since the medication lasts 16hours, youre likely to sleep through any discomfort and can enjoy the amorouseffects when the sun comes up.

This hormone suppository can ease vaginal dryness and discomfort in postmenopausal women. Some women with low libido find it increases genital sensitivity (in a good way).

Testosterone can treat low libido in women but its not approved by the Food and Drug Administration, so this off-label use is controversial. It can cause side effects, including acne, hair loss, facial hair growth and mood changes.

Medications arent always the best way to deal with a limp libido. Sometimes, low sex drive is related to psychological issues, such as poor body image, past negative sexual experiences, trust issues or relationship problems. In those cases, it can help to work through your thoughts and feelings with a mental health professional.

And some women just need a crash course in sex education,Dr. Thacker says. Learning the ins and outs of your sexual anatomy includingthe importance of clitoral and G-spot stimulation can also improve desire,she adds. After all, if it doesnt feel good, you wont crave it.

And remember that you can have a healthy sex drive withoutbeing a seductress. Most women just arent thinking about sex that often. Theyhave a more responsive reaction to sex, Dr. Thacker says.

You dont have to be the initiator to enjoy a roll in thehay. You just have to be open to it, she adds. Its like exercise: You may notfeel like doing it, but once you start, youre usually glad you did.

Original post:
What Help Is Available for Low Sex Drive in Women? - Health Essentials from Cleveland Clinic

Betatrophin, which regulates glucose metabolism, is primarily expressed in liver and fat tissue. We aimed to investigate betatrophin levels in patients with polycystic ovary syndrome (PCOS) that is the most common endocrine pathology in women of reproductive age. A total of 69 women were included in this prospective study: 35 patients with PCOS (18 obese and 17 lean) and 34 healthy controls (17 obese and 17 lean). Patients who met the criteria were compared regarding betatrophin levels and other hormonal values. Serum betatrophin level did not differ between obese PCOS patients and obese controls, and lean PCOS patients and lean controls; while significantly increased in obese PCOS patients and controls compared to lean PCOS patients and controls. Total testosterone and androstenedione were significantly higher in patients with PCOS than in controls both in the obese and lean groups, while sex hormone-binding globulin was significantly lower in patients with PCOS than in controls both in the obese and lean groups. However, remaining hormone values were similar between groups. Betatrophin level was significantly increased in obese patients compared to lean patients independent to the presence of PCOS.

See more here:
Serum betatrophin levels are significantly increased in obese patients compared to lean patients regardless to the presence of PCOS. - Physician's...

If you havent heard of shilajit before, dont be distressed; you are not the only one. This superfood has been gaining traction and popularity just recently, and a lot of us are still oblivious to the amazing benefits of shilajit.

So, what exactly is shilajit? The name might sound unusual and unfamiliar, but the health benefits are nothing short of a wonder. Shilajit, also sometimes called mineral pitch, is found mainly in the rocks of Himalaya, the Tibet mountains, Altai, and Caucasus mountains. But you dont have to go so far in the mountains to find this wonderful product; you can easily order from Superfoods Australia.

How is the shilajit formed? This wonderful substance is the result of a long process of decomposition of plant matter and minerals over centuries. It was traditionally sourced from India and Tibet, but the range of sources has widened to many countries. It looks like black tar and feels sticky, gooey, and glutinous. Even though the sight might be unseemly and unwelcoming, if taken properly, shilajit promotes better strength and endurance.

Read below to find out more about the health benefits of shilajit.

One of the most common types of nutrient deficiency, iron deficiency, is the most common type of anemia. Iron deficiency anemia can be caused by a low-iron diet or the bodys inability to absorb iron and blood loss.

Iron is essential in the formation of red blood cells in the form of hemoglobin and myoglobin. Hemoglobin transports oxygen from the lungs to the rest of the tissues of the body, and myoglobin stores the oxygen for use when there is a shortage, especially during exercises.

Along with other minerals, shilajit is rich in iron and humic acid. Shilajit supplements can slowly increase the level of iron in the blood. It also contains fulvic acid, which helps in better absorption of vitamins and minerals. Not only does it help in better absorption, but it also increases the potency of vitamins and minerals.

If you are not sure whether you suffer from iron deficiency anemia or not, watch out for these symptoms: fatigue, headache, weakness, irregular heartbeat, and cold hands and feet. Before you decide to take shilajit supplements for iron deficiency anemia, its advisable to consult a doctor.

Shilajit is a powerful ayurvedic medicine or supplement for boosting endurance and strength. As we mentioned above, it is rich in fulvic acid, and this compound contains almost 45% oxygen. The high oxygen content can offset the increase of lactic acid and carbon dioxide during exercise.

Shilajit can also help prevent the symptoms of Chronic Fatigue Syndrome. It is a long-term condition that causes fatigue and tiredness. Even the simplest task can be a challenge when you suffer from CFS.

CFS occurs when your cells dont make enough energy due to mitochondrial dysfunction. Research on lab rats has shown that shilajit can help reduce fatigue and restore energy.

Fulvic acid is a powerful antioxidant, and the amount of it in shilajit makes it a powerful ally of the brain. Our nervous system is composed of many important proteins, and one of them is Tau protein, but an accumulation of Tau protein can trigger damage to brain cells. Fulvic acid prevents the buildup of tau protein and improves cognitive health.

The accumulation of tau protein and inflammation in the brain are the leading causes of diseases like Alzheimers. Drug treatments are available for Alzheimers, but shilajit can prevent or reduce the symptoms. More research and clinical trials need to be carried out before a solid conclusion can be reached.

We are all well aware that testosterone is primarily a male sex hormone, but did you know it is found in both men and women? Apart from the development of male sexual organs, it is also needed for the development of bone mass and muscles in both men and women. Its also a source of energy and brain function.

As we grow old, the testosterone level normally decreases. The signs of a low level of testosterone are low libido or low sex drive, reduced production of semen in men, hair loss, fatigue, mood fluctuations, loss of sleep, increased body fat, and loss of muscle mass.

One study on healthy men of ages 45-55 years showed a significant rise in the level of total testosterone after taking purified shilajit for ninety consecutive days.

Rich in fulvic acid, an antioxidant and anti-inflammatory compound, shilajit is potent in reducing free radicals and cellular damage. These two factors are important in reducing the effect of aging. Regular use of shilajit can boost longevity and slow down the aging process.

Side-effects

This is a natural and safe herb, but like any other herb, you shouldnt consume unprocessed and raw Shilajit. Raw and unprocessed shilajit contains heavy metal ions, fungus, free radicals, and other harmful substances that can make one sick. You should only buy purified shilajit to reduce any side-effects.

Also, keep in mind that shilajit is not yet FDA approved, and it isnt monitored for quality, strength, and/or purity. Before you decide to buy shilajit, be sure to meticulously research your options and choose a reputable source like Superfoods Australia.

Dont take this supplement if you suffer from any of these diseases: sickle cell anemia, thalassemia, or hemochromatosis. Theres also a chance of a small percentage of people to be allergic to shilajit. If you show signs of rash, dizziness, and/or an increased pulse, immediately stop taking shilajit.

How to use

Instructions will obviously come with every pack that you buy. Shilajit can be bought as powder supplements or in liquid form. For a liquid supplement, mix pea size in liquids and drink at least one to three times a day. For powder supplements, you can take it with milk twice daily. Check the instructions before you decide on how much to consume every day, but it shouldnt exceed 300 to 500 mg per day.

Shilajit has more health benefits to offer than just the five listed above. You can also use it as a pre-workout supplement and for enhanced sports performance. Try shilajit for at least 2 weeks before you see any results, and make sure to consult a doctor before you decide to take shilajit.

Originally posted here:
The Wondrous World Of Shilajit Five Health Benefits And Side-Effects - SCOOP EMPIRE

Testosterone Replacement Therapy Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The report encompasses the competition landscape entailing share analysis of the key players in the Testosterone Replacement Therapy market based on their revenues and other significant factors. Report analyzes changing trends and competitive analysis which becomes essential to monitor performance and make critical decisions for growth and development. It also provides market information in terms of development and its capacities.

Some of the Top companies operating in Global Testosterone Replacement Therapy Market are: Endo International, AbbVie, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals.

Download Sample copy of this Premium report @:

http://www.a2zmarketresearch.com/sample?reportId=175624

This study provides an evaluation of aspects that are expected to impact growth of market in an undesired or constructive method. The Testosterone Replacement Therapy market has been consistently examined with respect to the corresponding market segments. Each year within the mentioned forecast period is concisely considered in terms of produce and worth in the regional as well as the global markets respectively. Technical expansions of the Testosterone Replacement Therapy market have been examined by focusing on different technical platforms, tools, and methodologies. The notable feature of this research report is, it incorporates clients demands as well as future progress of this market across the global regions.

The report is presented in a clear and concise manner so that readers can understand the market structure and dynamics effectively. Recent trends and developments in the global Testosterone Replacement Therapy market have been analyzed. Opportunities leading to the growth of the market have been analyzed and stated. The report focuses on the global market, and answers some of the most critical questions stakeholders are currently facing across the globe. Information about the size of the market (by the end of the forecast year), companies that are most likely to scale up their competitive abilities, leading segments, and challenges impeding the growth of the market are given.

Global Testosterone Replacement Therapy Market Segmentation:

Segmentation by Type:

GelsInjectionsPatchesOthers

Segmentation by Application:

HospitalsClinicsOthers

Buy Exclusive Report on Global Testosterone Replacement Therapy Market Only @ 2800 USD:

http://www.a2zmarketresearch.com/buy?reportId=175624

Key Influence of the Testosterone Replacement Therapy Market report:

For any Query or Customization Before Buying, Visit @:

http://www.a2zmarketresearch.com/enquiry?reportId=175624

Table of Contents

Global Testosterone Replacement Therapy Market Research Report 2020 2026

Chapter 1 Testosterone Replacement Therapy Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Testosterone Replacement Therapy Market Forecast

If you have any special requirements, please let us know and we will offer you the report as you want.

Read more from the original source:
Massive Demand of Testosterone Replacement Therapy Market by 2020-2026 with Top Key Players like Endo International, AbbVie, Eli lilly, Pfizer,...

People running on an athletics track. (Pexels/Snapwire)

A bill that would bar transgender students from girls sports teams and force girls whose gender is questioned to submit to a genital examination was dealt a heavy blow by lawmakers last week.

New Hampshire politicians voted 13-7 to kill off the bill, saying it is inexpedient to legislate.

House Bill 1251 would bar transgender athletes from girls sports teams with a requirement that participants be cisgender.

The bill would mean that any female athlete whose gender was called into question would need to prove their sex via an analysis of their chromosomes, medical testing of their testosterone levels, and an examination of their external genitalia.

According to the sponsors of the bill, all 11 of whom are Republicans, this is necessary to protect fairness in sport, because they claim that trans athletes have an unfair physical advantage.

While Republicans said that passing the bill would preserve opportunities for female athletes, Democrats said it would take away opportunities for trans girls, an already marginalised group.

I have to tell you, Im really outraged by this bill, said Rosemarie Rung, a Merrimack Democrat.

I read where in primary school, a fourth grader who may identify as a female would have to be subject to internal and external reproductive anatomy. An analysis of the individuals chromosomes.

Currently there is no state-level guidance on trans students participation in sports, but many already play for female sports teams.

The New Hampshire Interscholastic Athletic Association has previously issued guidance to schools urging them to include trans girls on female sports teams.

This really is a wolfs in sheeps clothing, said Stephen Woodcock, a Conway Democrat. This is about not allowing transgender youth to participate.

A separate lawsuit seeking to bar trans girls from student sports on the basis they have an unfair physical advantage was seriously undermined last month, when one of the cisgender girls bringing the case beat her trans rival in a race.

The New Hampshire bill has been blasted by Democrats and LGBT+ activists, who point out that it would discriminate against trans athletes and could make trans students feel isolated.

They also argue that House Bill 1251 would set New Hampshire back, after gains made for LGBT+ rights in the past two years.

In May 2018, New Hampshire became the first Republican-controlled state to pass trans rights protections, and a year later it became the 13th US state to add an X gender option to drivers licenses.

House Bill 1251 will be taken up by the full House at a later date.

Read more from the original source:
Disgusting anti-trans bill forcing girls to face a genital exam so they can play sports is dealt a heavy blow - PinkNews

Article courtesy of: T. Hertoghe, MD, author of Testosterone, the Therapy for Real Gentlemen

The potent effects of testosterone therapy and its abuse by sports players has put use of this therapy under controversy for decades. In 2020, the discussion on whether or not to treat men who have testosterone-deficiency symptoms and levels with testosterone is possibly over, belonging to the past. The scientific data gathered and published in support of testosterone-deficient men, generally older than 30 years, using testosterone therapy are abundant and relevant. There is also ample information on how to monitor testosterone treatment and problems that may potentially ensue.

Testosterone therapy can safely and efficiently help prevent and reduce the severity of many age-related disorders

Medical research has now shown that it is safe to treat with testosterone therapy all types of testosterone-deficient patients, even those with active (untreated) prostate cancer, a topic we will talk about in another article. Testosterone therapy has also been found to make the mind stronger, reducing the incidence and impacts of anxiety and depressive disorders. It also helps mental functioning, boosting memory and even serving as one of the tools to slow down and oppose the development of Alzheimers disease. More than 80% of the studies published on the topic in peer-reviewed medical journals have shown that testosterone therapy improves heart conditions. Moreover, testosterone therapy has been reported to help prevent, oppose, and even reverse the development of obesity, type II diabetes, sarcopenia, osteoporosis, stroke, cachexia, etc. By preventing and alleviating age-related disorders testosterone therapy may make men also live longer.

Recent evidence that testosterone deficiency may shorten life and supplementation of it may extend life

Paucity of studies on the effects of testosterone deficiency and therapy on longevity two decades ago

Two decades ago, there were almost no studies showing that testosterone deficiency could increase the risk of premature death and that testosterone therapy could potentially extend the life span. Now, we have the studies. In medicine, researchers seldom write down in a publication that the therapy they used could improve longevity in their patients. It sounds too positive, not serious enough to publish in medical journals. Most investigators prefer using the less positive terminology of reducing mortality, which produces a more scientific impression. However, increasing longevity and reducing mortality are basically the same.

I found 35 studies published in peer-reviewed medical journals that show that higher blood levels of testosterone (within the reference range) are associated with a significantly increased longevity. Low testosterone levels that may increase mortality are usually low-normal within the reference range (in the lower two-thirds, lower half, lower third, lower quartile, or lower quintile of the reference range), and below the lower reference limit for testosterone is below the lower reference limit for testosterone in a laboratory test or a. The association of increasingly greater longevity at progressively higher testosterone levels suggests that the lack of testosterone causes or contributes to premature death. Furthermore, 9 studies have shown that testosterone therapy significantly increases longevity (or, if you prefer lowers mortality). In other words, older men who take testosterone may live longer.

There are a few studies showing no effects of testosterone therapy, and almost no study showing the opposite. The balance is visibly in favor of providing testosterone therapy to men with mild to severe testosterone deficiencies to keep them alive longer.

To access the relevant data on testosterone deficiency, testosterone therapy, and their association with longevity visit the International Hormone Society website, in the Evidence-based hormone therapies section.

To get more references and practical information on testosterone therapy, read my 600-page book for physicians, Testosterone, the Therapy for Real Gentlemen.

To get practical and in-depth training in testosterone therapy, attend the hormone therapy workshop in Orlando, May 15-16, 2020. Check out the Evidence-based hormone therapy workshop here,which will be available at the A4M 28th Annual Spring Congress being held in Orlando, Florida on May 14-16, 2020.

See the rest here:
Can Men Live Longer By Taking Testosterone Therapy? - Anti Aging News

Page 73«..1020..72737475..8090..»

Home » Testosterone » Page 73